COMPUGROUP MEDSPADR Financials
| COPA Stock | EUR 20.80 0.20 0.97% |
COMPUGROUP |
Understanding current and past COMPUGROUP MEDSPADR Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of COMPUGROUP MEDSPADR's financial statements are interrelated, with each one affecting the others. For example, an increase in COMPUGROUP MEDSPADR's assets may result in an increase in income on the income statement.
COMPUGROUP MEDSPADR Stock Summary
COMPUGROUP MEDSPADR competes with Veeva Systems, 10X GENOMICS, Healthequity, Teladoc, and Evolent Health. KGaA develops and sells software and information technology solutions for the healthcare sector worldwide. KGaA was founded in 1987 and is headquartered in Koblenz, Germany. COMPUGROUP MED is traded on Frankfurt Stock Exchange in Germany.| Foreign Associate | USA |
| Instrument | Germany Stock View All |
| Exchange | Frankfurt Exchange |
| ISIN | US20481P1003 |
| Business Address | Maria Trost 21 |
| Sector | Healthcare |
| Industry | Health Information Services |
| Benchmark | Dow Jones Industrial |
| Website | www.cgm.com |
| Phone | 49 261 8000 0 |
| Currency | EUR - Euro |
You should never invest in COMPUGROUP MEDSPADR without having analyzed its financial statements. Do not rely on someone else's analysis or guesses about the future performance of COMPUGROUP Stock, because this is throwing your money away. Analyzing the key information contained in COMPUGROUP MEDSPADR's financial statements can give you an edge over other investors and help to ensure that your investments perform well for you.
COMPUGROUP MEDSPADR Key Financial Ratios
There are many critical financial ratios that COMPUGROUP MEDSPADR's investors are exposed to on a daily basis, but they are usually grouped into few meaningful categories from each financial statement that COMPUGROUP MEDSPADR reports annually and quarterly.COMPUGROUP Financial Ratios Relationships
Comparative valuation techniques use various fundamental indicators to help in determining COMPUGROUP MEDSPADR's current stock value. Our valuation model uses many indicators to compare COMPUGROUP MEDSPADR value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across COMPUGROUP MEDSPADR competition to find correlations between indicators driving COMPUGROUP MEDSPADR's intrinsic value. More Info.COMPUGROUP MEDSPADR 1 is rated below average in return on equity category among its peers. It also is rated below average in return on asset category among its peers reporting about 0.28 of Return On Asset per Return On Equity. The ratio of Return On Equity to Return On Asset for COMPUGROUP MEDSPADR 1 is roughly 3.61 . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the COMPUGROUP MEDSPADR's earnings, one of the primary drivers of an investment's value.COMPUGROUP MEDSPADR Systematic Risk
COMPUGROUP MEDSPADR's systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. COMPUGROUP MEDSPADR volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The output start index for this execution was twenty with a total number of output elements of fourty-one. The Beta measures systematic risk based on how returns on COMPUGROUP MEDSPADR correlated with the market. If Beta is less than 0 COMPUGROUP MEDSPADR generally moves in the opposite direction as compared to the market. If COMPUGROUP MEDSPADR Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one COMPUGROUP MEDSPADR is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of COMPUGROUP MEDSPADR is generally in the same direction as the market. If Beta > 1 COMPUGROUP MEDSPADR moves generally in the same direction as, but more than the movement of the benchmark.
COMPUGROUP MEDSPADR December 23, 2024 Opportunity Range
Along with financial statement analysis, the daily predictive indicators of COMPUGROUP MEDSPADR help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of COMPUGROUP MEDSPADR 1. We use our internally-developed statistical techniques to arrive at the intrinsic value of COMPUGROUP MEDSPADR 1 based on widely used predictive technical indicators. In general, we focus on analyzing COMPUGROUP Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build COMPUGROUP MEDSPADR's daily price indicators and compare them against related drivers.
| Downside Deviation | 4.56 | |||
| Information Ratio | 0.1224 | |||
| Maximum Drawdown | 44.01 | |||
| Value At Risk | (7.38) | |||
| Potential Upside | 11.94 |
Complementary Tools for COMPUGROUP Stock analysis
When running COMPUGROUP MEDSPADR's price analysis, check to measure COMPUGROUP MEDSPADR's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy COMPUGROUP MEDSPADR is operating at the current time. Most of COMPUGROUP MEDSPADR's value examination focuses on studying past and present price action to predict the probability of COMPUGROUP MEDSPADR's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move COMPUGROUP MEDSPADR's price. Additionally, you may evaluate how the addition of COMPUGROUP MEDSPADR to your portfolios can decrease your overall portfolio volatility.
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
| Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios |